Skip navigation
All CNBC  |  News  |  Video


Company: Novartis AG
Novartis AG : [NVS  Loading...      ()   ]
 | Source: The Associated Press
Human Genome Sciences Inc. said Wednesday it has filed for marketing approval of its hepatitis C drug Zalbin.
 | Source: The Associated Press
Drug developer Incyte Corp. on Wednesday licensed two potential drugs, including a treatment for myelofibrosis, to Swiss drugmaker Novartis AG In a deal that could be worth more than $1.3 billion.
Tuesday, 17 Nov 2009 | Source: Reuters
A U.S. clinical study suggests that just half a dose of the Novartis AG H1N1 vaccine may be enough to generate a protective immune response, the Swiss drugmaker said on Tuesday.
Friday, 13 Nov 2009 | Source: The Associated Press
Serbia's health authorities have ordered three million swine flu vaccines from Swiss pharmaceutical company Novartis AG worth an estimated euro24 million ($36 million).
Wednesday, 11 Nov 2009 | Source: Reuters
GlaxoSmithKline has won U.S. marketing approval to sell an unadjuvanted H1N1 swine vaccine, allowing it to ship relatively modest amounts of scarce vaccine to the United States next month.
Tuesday, 27 Oct 2009 | Source: Reuters
GlaxoSmithKline has yet to get U.S. government approval for its swine flu vaccine, the company said Tuesday, while Novartis said it was still struggling to make vaccines.
Thursday, 22 Oct 2009 | Posted By: Cindy Perman | Source: CNBC.com
Stocks advanced Thursday as investors seemed to focus more on some big-name earnings beats and a rise in leading indicators instead of a disappointing jobless report. Travelers and MMM led the Dow.
Thursday, 22 Oct 2009 | Posted By: Mike Huckman | Source: CNBC.com
Swiss drug giant Novartis says it has redeployed 300 workers from other divisions into its vaccines unit to meet what Chairman and CEO Dr. Daniel Vasella calls the "huge demand" for H1N1 shots.
Thursday, 22 Oct 2009 | Source: CNBC.com
Stocks advanced Thursday as investors seemed to focus more on some big-name earnings beats and a rise in leading indicators instead of a disappointing jobless report.
Thursday, 22 Oct 2009 | Source: CNBC.com
Stocks slipped Thursday as investors weighed a disappointing jobless-claims report and some encouraging earnings reports.
Thursday, 22 Oct 2009 | Source: CNBC.com
Earnings continue to come in largely above expectations, but other factors are waylaying the stock market's recent advances - ranging from Walmart's price cuts to analyst Richard Bove's downgrade of Wells Fargo to rising oil prices. 
Monday, 12 Oct 2009 | Posted By: Mike Huckman | Source: CNBC.com
Novartis is buying back the rights to a schizophrenia pill that it sold to another company years ago after it decided the drug wasn't worth pursuing.
Tuesday, 29 Sep 2009 | Posted By: Krystina Gustafson | Source: CNBC.com
Major US companies are bracing for a potentially stronger strain of swine flu this year that could threaten the nation's already fragile economic recovery.
Tuesday, 15 Sep 2009 | Source: The Associated Press
The Food and Drug Administration approved the new swine flu vaccine Tuesday, a long-anticipated step as the government works to get vaccinations under way next month.
Thursday, 9 Jul 2009 | Source: CNBC.com
As the Markey-Waxman bill on carbon emissions cap-and-trade makes it way through the Senate, a new carbon-counting reality may soon be here for American businesses.
Next
Posts |  COMPANY : Novartis AG
For the second time in three weeks I'm at a flu vaccine manufacturing plant today... Read More
23 Nov 2009
Posted By:Lightning Round
Cramer makes the call on viewers' favorite stocks.... Read More
10 Nov 2009
Many analysts, lobbyists and industry executives have been saying for months that healthcare reform would probably end up being a net positive for the drug companies... Read More
4 Nov 2009
Posted By:Lee Brodie | Rapid Recap
You know that Tim Seymour is bullish on China but now he’s got three new reasons to get long... Read More
28 Oct 2009
GlaxoSmithKline is one of the handful of drug companies on the front lines of the fight against the flu... Read More
VIDEO | COMPANIES : Novartis AG
Evidence in favor of a rebalancing in the global economy remains scant, notes Kevin Gaynor, chief markets economist at R...
Novartis is trying to get ahead of the game with the first-ever U.S. based plant to make cell-based flu vaccines, with D...
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are...
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are...


Current DateTime: 01:02:06 25 Nov 2009
LinksList Documentid: 23188555



Current DateTime: 01:02:06 25 Nov 2009
LinksList Documentid: 23188557

Current DateTime: 05:21:40 25 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 08:51:31 25 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 02:05:46 25 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 08:49:59 25 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters